MonsterPennyPick - Sign up for our Research Reports covering the most popular small-cap and micro-cap companies now. We work hard to locate the next hottest penny stock.
New York, NY -- (SBWIRE) -- 11/15/2012 -- Medical Marijuana, Inc. (PINK:MJNA) is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. MJNA is showing an ongoing increase in gains as investors push the stock up another $.0149 (12.96%) bringing the intraday trade price up to $.1299 with about 6.2 million shares exchanged. Can MJNA continue to push higher without news? Stick around.
Taglikeme Corp. (PINK:TAGG) is an internet media and digital information technology company. The Company is engaged in the business of connecting online users with others.Tagg is showing an ongoing increase in gains as investors push the stock up another $.0056 (7.52%) bringing the intraday trade price up to $.0801 with about 3 million shares exchanged. Can TAGG continue to push its share value higher without news? Stick around.
Cannabis Science, Inc. (PINK:CBIS) is a development-stage company. The Company is in the business of developing pharmaceutical grade medical cannabis products. On August 18, 2010, the Company entered into a license agreement with Rockbrook, Inc. to license its medical cannabis products and delivery methods. This dormant stock has emerged today as a huge gainer as it soared up $.0023 (2.90%) bringing the intraday trade price to $.0815 with about 1.15 Million shares exchanged. Can CBIS gain enough investors to push it up more or will they pull back for profits? Stick around.
Amarantus Biosciences, Inc. (OTC:AMBS) is a California-based development-stage biotechnology company founded in January 2008. The Company focuses on developing its intellectual property and proprietary technology to develop drug candidates to treat human disease. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF). MANF is a protein that corrects protein misfolding.Currently, the stock is up $0.0057(14.62%) bringing the intraday trade price up to $.0447 with close to 4 million shares exchanged.
Colorado Ceramic Tile (OTC:CTLE) is prepared to meet all your hard surfacing needs! We carry a variety of products including ceramic and porcelain tile, natural stone, glass, metal accents, hardwood flooring, rubber and leather flooring, and engineered counter surfaces. CTLE is trending higher as more investors accumulate shares of the stock without news released. The stock has increased $.03 (2.56%) bringing the intraday trade price up to $1.20 with about 130k shares exchanged.
You can find the full report at: http://www.monsterpennypick.com/content/penny-stocks-focus-mjna-tagg-cbis-ambs-ctle
We provide in-depth research on the next potential Micro-cap or Nano-cap company on the rise. Please sign up for our free newsletter now.
None of the companies issued by MonsterPennyPick.com in our daily market research blog, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. MonsterPennyPick.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on MonsterPennyPick.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that MonsterPennyPick.com employees are not Registered as an Investment Advisor in any jurisdiction
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)